Among the Ly6/uPAR members, LY6K (also named cancer-testis antigen) has been identified as a putative oncogene with elevated expression in several cancers, such as breast, head-and-neck, bladder, lung, and eraesophageal cancers. Here, PLAUR is linked to cancer.